Crinetics Pharmaceuticals (CRNX) Current Leases (2021 - 2025)
Historic Current Leases for Crinetics Pharmaceuticals (CRNX) over the last 5 years, with Q3 2025 value amounting to $6.4 million.
- Crinetics Pharmaceuticals' Current Leases fell 1311.21% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 1311.21%. This contributed to the annual value of $7.2 million for FY2024, which is 7138.75% up from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Current Leases is $6.4 million, which was down 1311.21% from $6.6 million recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Current Leases ranged from a high of $7.4 million in Q2 2024 and a low of $939000.0 during Q4 2021
- In the last 5 years, Crinetics Pharmaceuticals' Current Leases had a median value of $5.0 million in 2023 and averaged $4.4 million.
- As far as peak fluctuations go, Crinetics Pharmaceuticals' Current Leases soared by 57132.55% in 2024, and later tumbled by 1311.21% in 2025.
- Quarter analysis of 5 years shows Crinetics Pharmaceuticals' Current Leases stood at $939000.0 in 2021, then grew by 11.93% to $1.1 million in 2022, then soared by 297.05% to $4.2 million in 2023, then skyrocketed by 71.39% to $7.2 million in 2024, then dropped by 9.94% to $6.4 million in 2025.
- Its Current Leases stands at $6.4 million for Q3 2025, versus $6.6 million for Q2 2025 and $6.9 million for Q1 2025.